Ciprofloxacin In Dextrose Injection, Solution
Product Images NDC 0409-2300

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin In Dextrose (NDC 0409-2300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cip0h 0001 01)

Chemical structure diagram of ciprofloxacin, showing its molecular framework with labeled atoms and bonds typical of fluoroquinolone antibiotics.*

FDA Label Image

Principal Display Panel – 100 mL Carton Label (Cip0h 0001 02)

Packaging label for Ciprofloxacin 200 mg/100 mL (2 mg/mL) injection solution in 5% Dextrose Injection, USP. The product is supplied in 24 x 100 mL bags and labeled with NDC 0409-2300-24. The label shows the Hospira logo and includes storage instructions, barcode, and recycling symbols. The label design is predominantly white with orange text.*

FDA Label Image

Principal Display Panel – 100 mL Pouch Label (Cip0h 0001 03)

Label for Ciprofloxacin 200 mg/100 mL (2 mg/mL) injection solution in 5% dextrose, intended for intravenous use. The label includes directions to infuse over 60 minutes, indicates the product is sterile and preservative-free, and provides storage instructions. Distributed by Hospira, Inc., the label features the NDC 0409-2300-01 and a barcode.*

FDA Label Image

Principal Display Panel – 100 mL Bag Label (Cip0h 0001 04)

Ciprofloxacin 200 mg/100 mL injection in 5% Dextrose solution label from Hospira, Inc. This single-dose flexible plastic container is for intravenous use and contains ciprofloxacin 200 mg and dextrose monohydrate 5 g per 100 mL. The label includes dosing information, cautions, and distributor details.*

FDA Label Image

Principal Display Panel – 200 mL Carton Label (Cip0h 0001 05)

Packaging label for Ciprofloxacin 400 mg/200 mL injection solution in 5% Dextrose Injection, USP. The label indicates 24 x 200 mL bags and displays the NDC 0409-3300-24. It is produced and distributed by Hospira, Inc., with storage instructions and a barcode visible on the label.*

FDA Label Image

Principal Display Panel – 200 mL Pouch Label (Cip0h 0001 06)

Label for Ciprofloxacin in Dextrose 400 mg/200 mL (2 mg/mL) injection, solution in a 200 mL flexible plastic container. It is a sterile, preservative-free intravenous infusion product by Hospira, Inc., made in India and distributed in Lake Forest, IL. The label includes usage cautions, storage instructions, and a barcode.*

FDA Label Image

Principal Display Panel – 200 mL Bag Label (Cip0h 0001 07)

Label for Ciprofloxacin 400 mg/200 mL (2 mg/mL) injection in 5% Dextrose, USP, an intravenous solution. The label highlights that the product is sterile, preservative-free, and nonpyrogenic. Distributed by Hospira, Inc., the label includes usage cautions, dosage guidance, and storage instructions. The label also features a barcode and a space for batch and expiration date information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.